{"id":"ethinyl-estradiol-cyproterone-acetate","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breakthrough bleeding"},{"rate":"3-4 per 10,000 woman-years","effect":"Venous thromboembolism"},{"rate":null,"effect":"Hypertension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ethinyl estradiol is a synthetic estrogen that inhibits FSH and LH secretion, suppressing ovulation and endogenous hormone production. Cyproterone acetate is a progestin with anti-androgenic properties that competitively blocks androgen receptors at target tissues. Together, they reduce circulating androgens and androgen-mediated effects, making this combination effective for conditions driven by excess androgens.","oneSentence":"Ethinyl estradiol suppresses gonadotropins while cyproterone acetate blocks androgen receptors, reducing androgenic effects in women.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:39:27.981Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"},{"name":"Acne vulgaris in women"},{"name":"Hirsutism"},{"name":"Androgenetic alopecia in women"},{"name":"Polycystic ovary syndrome (PCOS)"}]},"trialDetails":[{"nctId":"NCT03043924","phase":"NA","title":"Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2017-09-26","conditions":"Polycystic Ovary Syndrome","enrollment":52},{"nctId":"NCT05316935","phase":"PHASE2, PHASE3","title":"GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients","status":"RECRUITING","sponsor":"Xiaojun Chen","startDate":"2022-07-13","conditions":"Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance","enrollment":80},{"nctId":"NCT02636972","phase":"","title":"The Progression From Dysmenorrhoea to Chronic Pelvic Pain","status":"COMPLETED","sponsor":"University of Adelaide","startDate":"2014-11","conditions":"Dysmenorrhoea, Pelvic Pain, Chronic Pain","enrollment":56},{"nctId":"NCT05657171","phase":"","title":"\"Effect of CPA/EE Drug on Periodontal Tissue and hsCRP Levels in PCOS Patients With Gingivitis","status":"COMPLETED","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2022-12-12","conditions":"Periodontal Diseases","enrollment":47},{"nctId":"NCT00280657","phase":"PHASE3","title":"Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03-10","conditions":"Acne Vulgaris","enrollment":1326},{"nctId":"NCT04984070","phase":"NA","title":"Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2021-01-01","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Depression, Anxiety","enrollment":100},{"nctId":"NCT02460445","phase":"NA","title":"Phlebotomy and Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Manuel Luque Ramírez","startDate":"2015-01","conditions":"Hyperandrogenism, Metabolic Cardiovascular Syndrome","enrollment":37},{"nctId":"NCT04831151","phase":"NA","title":"The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics","status":"UNKNOWN","sponsor":"Inonu University","startDate":"2021-03-01","conditions":"Polycystic Ovary Syndrome","enrollment":42},{"nctId":"NCT04964193","phase":"NA","title":"Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers","status":"COMPLETED","sponsor":"PT Sydna Farma","startDate":"2019-03-12","conditions":"Drug Use","enrollment":24},{"nctId":"NCT05021861","phase":"","title":"Evaluation of Periodontal Status and hsCRP Levels in Females With PCOS on CPA/EE Combination Drug Regimen","status":"UNKNOWN","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2021-11","conditions":"Periodontitis, Polycystic Ovary Syndrome, Gingivitis","enrollment":150},{"nctId":"NCT02494297","phase":"","title":"DUS on the Prescribing Indications for CPA/EE in 5 European Countries","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2015-03-06","conditions":"Hirsutism, Androgenetic Alopecia, Severe Anemia","enrollment":1597},{"nctId":"NCT02689843","phase":"EARLY_PHASE1","title":"Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2018-02-01","conditions":"Polycystic Ovary Syndrome","enrollment":90},{"nctId":"NCT02729545","phase":"PHASE2","title":"The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Beijing Hospital of Integrated Traditional Chinese and Western Medicine","startDate":"2016-04","conditions":"Polycystic Ovarian Syndrome","enrollment":60},{"nctId":"NCT02866786","phase":"PHASE4","title":"The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS","status":"COMPLETED","sponsor":"S.C.B. Medical College and Hospital","startDate":"2016-08-15","conditions":"Polycystic Ovary Syndrome","enrollment":101},{"nctId":"NCT03236740","phase":"PHASE4","title":"OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS","status":"COMPLETED","sponsor":"S.C.B. Medical College and Hospital","startDate":"2017-08-01","conditions":"PCOS","enrollment":101},{"nctId":"NCT03264638","phase":"PHASE2","title":"A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS","status":"UNKNOWN","sponsor":"Aijun Sun","startDate":"2016-10-01","conditions":"PCOS","enrollment":315},{"nctId":"NCT02410031","phase":"","title":"Risk Minimisation Study for Diane-35 and Its Generics","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-06-26","conditions":"Acne Vulgaris","enrollment":759},{"nctId":"NCT02349399","phase":"","title":"Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-05-01","conditions":"Acne Vulgaris","enrollment":26065},{"nctId":"NCT02599077","phase":"PHASE2, PHASE3","title":"Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas","status":"SUSPENDED","sponsor":"Fundación Santa Fe de Bogota","startDate":"2015-11","conditions":"Endometriosis","enrollment":50},{"nctId":"NCT02027337","phase":"PHASE4","title":"Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants","status":"UNKNOWN","sponsor":"Tyumen State Medical Academy","startDate":"2013-12","conditions":"Polycystic Ovarian Syndrome, Hyperandrogenism, Menstrual Irregularities","enrollment":200},{"nctId":"NCT01573377","phase":"NA","title":"Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2012-02","conditions":"Polycystic Ovary Syndrome, Insulin Resistance","enrollment":40},{"nctId":"NCT01798875","phase":"PHASE4","title":"PCOS, Therapy and Markers of Cardiovascular Risk","status":"UNKNOWN","sponsor":"Medical University of Gdansk","startDate":"2012-04","conditions":"PCOS","enrollment":50},{"nctId":"NCT00752635","phase":"PHASE4","title":"Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Johnson & Johnson Taiwan Ltd","startDate":"2004-09","conditions":"Acne Vulgaris","enrollment":48},{"nctId":"NCT01103518","phase":"PHASE4","title":"Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation","status":"UNKNOWN","sponsor":"Fundação Educacional Serra dos Órgãos","startDate":"2009-12","conditions":"Amenorrhea, Dysmenorrhea, Menstruation Disturbances","enrollment":100},{"nctId":"NCT00428311","phase":"PHASE4","title":"Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS","status":"COMPLETED","sponsor":"Hospital Universitario Ramon y Cajal","startDate":"2004-04","conditions":"Polycystic Ovary Syndrome","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ethinyl Estradiol + Cyproterone acetate","genericName":"Ethinyl Estradiol + Cyproterone acetate","companyName":"Fundação Educacional Serra dos Órgãos","companyId":"funda-o-educacional-serra-dos-rg-os","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethinyl estradiol suppresses gonadotropins while cyproterone acetate blocks androgen receptors, reducing androgenic effects in women. Used for Contraception, Acne vulgaris in women, Hirsutism.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}